{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:19:15Z","timestamp":1792819155377,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["956544"],"award-info":[{"award-number":["956544"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019188","name":"HORIZON EUROPE Excellent Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.addr.2022.114396","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T01:00:06Z","timestamp":1656982806000},"page":"114396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["A brief history of long circulating nanoparticles"],"prefix":"10.1016","volume":"188","author":[{"given":"H.B.","family":"Haroon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.S.","family":"Farhangrazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2022.114396_b0005","first-page":"31","article-title":"Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection","volume":"11","author":"Moghimi","year":"1994","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.addr.2022.114396_b0010","first-page":"484","article-title":"Relationship between localization and function of rat liver Kupffer cells","volume":"233","author":"Sleyster","year":"1982","journal-title":"Lab. Invest."},{"key":"10.1016\/j.addr.2022.114396_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1011054123304","article-title":"Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups","volume":"18","author":"Moghimi","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114396_b0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/01926230590522365","article-title":"Liver immunobiology","volume":"33","author":"Parker","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.addr.2022.114396_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-409X(97)00131-2","article-title":"Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system \u2014 The concept of tissue specificity","volume":"32","author":"Moghimi","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0035","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.1021\/acsnano.5b05061","article-title":"Modulatory role of surface coating of superparamagnetic iron oxide nanoworms in complement opsonisation and leukocyte uptake","volume":"9","author":"Inturi","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2022.114396_b0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010611-134623","article-title":"Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective","volume":"52","author":"Moghimi","year":"2011","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2022.114396_b0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1389200219666171207120643","article-title":"Long circulating polymeric nanoparticles for gene\/drug delivery","volume":"19","author":"Hu","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.addr.2022.114396_b0050","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.apsb.2021.11.016","article-title":"The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both drug payloads and nanocarriers","volume":"12","author":"Fan","year":"2021","journal-title":"Acta Pharm. Sinica B"},{"key":"10.1016\/j.addr.2022.114396_b0055","first-page":"958","article-title":"Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation","volume":"232","author":"Chambers","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.addr.2022.114396_b0060","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.addr.2022.114396_b0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.117.1.139","article-title":"The mechanism of blockade of the reticuloendothelial system","volume":"117","author":"Murray","year":"1963","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2022.114396_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.122.1.117","article-title":"The dynamics of reticuloendothelial blockade","volume":"122","author":"Koenig","year":"1965","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2022.114396_b0075","unstructured":"R.M. Abra, M.E. Bosworth, M. E., A.C. Hunt, Liposome disposition in vivo: effects of pre-dosing with liposomes. Res. Commun. Chem. Pathol. Pharmacol. 29 (1980) 349\u2013360."},{"key":"10.1016\/j.addr.2022.114396_b0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0304-4165(81)90366-4","article-title":"The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes","volume":"674","author":"Souhami","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0085","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1166\/jbn.2018.2603","article-title":"Reticuloendothelial system pre-block strategy to improve tumor targeting efficacy for hyaluronic acid related drug delivery system","volume":"14","author":"Liu","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.addr.2022.114396_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7150\/thno.18078","article-title":"Improved Tumor uptake by optimizing liposome based RES blockade strategy","volume":"7","author":"Sun","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2022.114396_b0095","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1021\/acs.nanolett.0c00752","article-title":"A nanoprimer to improve the systemic delivery of siRNA and mRNA","volume":"20","author":"Saunders","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2022.114396_b0100","first-page":"178","article-title":"Transient suppression of macrophage functions by liposome-encapsulated drugs, Trend","volume":"15","author":"van Rooijen","year":"1997","journal-title":"Biotechnol."},{"key":"10.1016\/j.addr.2022.114396_b0105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jlb.52.3.296","article-title":"Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation","volume":"52","author":"Hardonk","year":"1992","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2022.114396_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0167-4889(89)90194-8","article-title":"Gadolinium chloride-induced shifts in intrahepatic distributions of liposomes","volume":"1011","author":"L\u00e1z\u00e1r","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep.1840050427","article-title":"The liver sieve: considerations concerning the structure and function of endothelial fenestra, the sinusoidal wall and the space of Disse","volume":"5","author":"Wisse","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.addr.2022.114396_b0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0163-7827(00)00020-5","article-title":"The role of hepatocytes in the clearance of liposomes from the blood circulation","volume":"40","author":"Scherphof","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.addr.2022.114396_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.735573","article-title":"The whole story about fenestrations in LSEC","volume":"12","author":"Szafranska","year":"2021","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.addr.2022.114396_b0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ar.20681","article-title":"Lymph circulation in the liver","volume":"291","author":"Ohtani","year":"2008","journal-title":"Anat. Rec."},{"key":"10.1016\/j.addr.2022.114396_b0135","first-page":"733","article-title":"The hepatic lymphatic vascular system: structure, function, markers, and lymphangiogenesis, Cell Mol","volume":"2","author":"Tanaka","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2022.114396_b0140","unstructured":"J.A. Barrowman, Hepatic lymph and lymphatics. In: Oxford Textbook of Clinical Hepatology (N. McIntyre, J.-P. Benhamou, J. Bircher, M. Rizzetto, eds.), New York: Oxford University Press, pp. 37\u201340."},{"key":"10.1016\/j.addr.2022.114396_b0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonisation and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.addr.2022.114396_b0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/jpet.119.258012","article-title":"The interplay between blood proteins, complement, and macrophages on nanomedicine performance and responses","volume":"370","author":"Moghimi","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2022.114396_b0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.04.012","article-title":"Complement activation by drug carriers and particulate pharmaceuticals: principles, challenges and opportunities","volume":"157","author":"Moghimi","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0014-5793(87)80506-9","article-title":"Large unilamellar liposomes with low uptake by the reticuloendothelial system","volume":"223","author":"Allen","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114396_b0165","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1073\/pnas.85.18.6949","article-title":"Liposome formulations with prolonged circulation time in blood and enhanced uptake in tumors","volume":"85","author":"Gabizon","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.addr.2022.114396_b0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5173(93)90297-S","article-title":"Effects of glycophorin and ganglioside GM3 on the blood circulation and tissue distribution of liposomes in rats","volume":"90","author":"Yamauchi","year":"1993","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.addr.2022.114396_b0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0005-2760(93)90290-P","article-title":"Effects of chemically modified GM1 and neoglycolipids analogs of GM1 on liposome circulation time: evidence supporting the dysopsonic hypothesis","volume":"1166","author":"Park","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0180","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1023\/A:1016274801930","article-title":"Antibody dependent, complement mediated liver uptake of liposome containing GM1","volume":"12","author":"Liu","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114396_b0185","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0006-291X(05)80266-9","article-title":"Complement-dependent phagocytosis of liposomes by macrophages. Suppressive effects of stealth lipids","volume":"176","author":"Wassef","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2022.114396_b0190","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.4049\/jimmunol.140.5.1581","article-title":"Effect of gangliosides on activation of the alternative pathway of human complement","volume":"140","author":"Michalek","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2022.114396_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nchembio.1696","article-title":"Structural basis for sialic acid-mediated self-recognition by complement factor H","volume":"11","author":"Blaum","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2022.114396_b0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(94)00188-B","article-title":"Effects of sialic acid derivatives on long circulation time and tumor concentration of liposomes","volume":"113","author":"Yamauchi","year":"1995","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.addr.2022.114396_b0205","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jconrel.2021.08.048","article-title":"Complement opsonisation of nanoparticles: differences between humans and preclinical species","volume":"338","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114396_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101479","article-title":"Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology","volume":"44","author":"Moghimi","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2022.114396_b0215","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0005-2736(89)90307-6","article-title":"Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes","volume":"984","author":"Moghimi","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0220","doi-asserted-by":"crossref","first-page":"128S","DOI":"10.1042\/bst021128s","article-title":"Serum factors that regulate phagocytosis of liposomes by Kupffer cells","volume":"21","author":"Moghimi","year":"1993","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.addr.2022.114396_b0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-5793(84)80836-4","article-title":"The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (poloxamer 338)","volume":"167","author":"Illum","year":"1984","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114396_b0230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0024-3205(87)90138-X","article-title":"The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer \u2013 poloxamine 908","volume":"40","author":"Illum","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2022.114396_b0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0142-9612(87)90099-8","article-title":"Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages","volume":"8","author":"Illum","year":"1987","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2022.114396_b0240","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/elps.11501401214","article-title":"Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis","volume":"14","author":"Blunk","year":"1993","journal-title":"Electrophoresis"},{"key":"10.1016\/j.addr.2022.114396_b0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0167-4889(93)90137-E","article-title":"Coating particles with a block co-polymer (poloxamine-908) suppresses opsonisation but permits the activity of dysopsonins in the serum","volume":"1179","author":"Moghimi","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i6.30","article-title":"Capture of stealth nanoparticles by the body\u2019s defences","volume":"18","author":"Moghimi","year":"2001","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.addr.2022.114396_b0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-5793(03)00273-4","article-title":"Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration","volume":"540","author":"Moghimi","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114396_b0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0005-2736(01)00376-5","article-title":"The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers","volume":"1514","author":"Stolnik","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0265","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1166\/jnn.2006.406","article-title":"Concentration dependent structural ordering of poloxamine-908 on polystyrene nanoparticles and their modulatory role on complement consumption","volume":"6","author":"Al-Hanbali","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.addr.2022.114396_b0270","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1021\/nn101990a","article-title":"Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere\u2014serum interface: implications for stealth nanoparticle engineering","volume":"4","author":"Hamad","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2022.114396_b0275","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0006-291X(91)91869-E","article-title":"Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating","volume":"177","author":"Moghimi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2022.114396_b0280","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-4165(93)90105-H","article-title":"An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen","volume":"1157","author":"Moghimi","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0285","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/cs0840605","article-title":"Effect of splenic congestion associated with haemolytic anaemia on filtration of \u2018spleen-homing\u2019 microspheres","volume":"84","author":"Moghimi","year":"1993","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.addr.2022.114396_b0290","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jlb.54.6.513","article-title":"Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats","volume":"54","author":"Moghimi","year":"1993","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2022.114396_b0295","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jnci\/88.11.766","article-title":"Poloxamer-188 revisited: a potentially valuable immune modulator?","volume":"88","author":"Moghimi","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.addr.2022.114396_b0300","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/cs0930371","article-title":"A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats","volume":"93","author":"Moghimi","year":"1997","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.addr.2022.114396_b0305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-4165(01)00142-8","article-title":"Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology","volume":"1526","author":"Laverman","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(97)00060-3","article-title":"Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A \u2018hepatic-blockade\u2019 event or manipulation of nanosphere surface in vivo?","volume":"1336","author":"Moghimi","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0315","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-5793(03)00707-5","article-title":"Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908","volume":"547","author":"Moghimi","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114396_b0320","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0024-3205(87)90120-2","article-title":"Targeting of colloidal particles to the bone marrow","volume":"40","author":"Illum","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2022.114396_b0325","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0014-5793(92)80655-Z","article-title":"The polyoxyethylene\/polyoxypropylene block co-polymer Poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow","volume":"305","author":"Porter","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114396_b0330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0005-2736(90)90440-Y","article-title":"Liposomes for sustained drug release in vivo","volume":"1029","author":"Blume","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphiphatic polyethyleneglycol effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114396_b0340","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1023\/A:1018931820564","article-title":"Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethyleneglycol) copolymers","volume":"11","author":"Stolnik","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114396_b0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(99)00063-2","article-title":"Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting","volume":"60","author":"Peracchia","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114396_b0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0169-409X(95)00025-3","article-title":"Long circulating microparticulate drug carriers","volume":"16","author":"Stolnik","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0355","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0360","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.addr.2022.114396_b0365","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.addr.2011.06.002","article-title":"Material properties in complement activation","volume":"63","author":"Moghimi","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0370","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","article-title":"Immunoglobulin deposition on biomolecule corona determines complement opsonisation efficiency of preclinical and clinical nanoparticles","volume":"14","author":"Vu","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2022.114396_b0375","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.bbamem.2006.12.013","article-title":"Influence of poly(ethylene glycol) grafting and polymer length on liposomes: relating plasma circulation lifetimes to protein binding","volume":"1768","author":"Dos Santos","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2022.114396_b0380","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1021\/acsnano.8b04947","article-title":"Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation","volume":"12","author":"Zhou","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2022.114396_b0385","first-page":"6134","article-title":"Chain mobility and film softness mediated protein antifouling at the solid\u2014liquid interface","volume":"4","author":"Liu","year":"2016","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.addr.2022.114396_b0390","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/acs.nanolett.0c01011","article-title":"Overcoming nanoparticle-mediated complement activation by surface PEG pairing","volume":"20","author":"Pannuzzo","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2022.114396_b0395","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 The first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114396_b0400","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u2018Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEH Chain length and surface density) on the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloid. Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2022.114396_b0405","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2022.114396_b0410","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1038\/s41467-021-24960-6","article-title":"Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2022.114396_b0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2022.114396_b0420","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2217\/nnm.15.38","article-title":"Disulfide-bridged cleavable PEGylation in polymeric nanomedicine for controlled therapeutic delivery","volume":"10","author":"Dong","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2022.114396_b0425","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1039\/c4nr00843j","article-title":"Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery","volume":"6","author":"Wang","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2022.114396_b0430","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.05.009","article-title":"Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives","volume":"130","author":"Xu","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114396_b0435","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1016\/j.biomaterials.2013.03.018","article-title":"pH-Responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells","volume":"34","author":"Dong","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2022.114396_b0440","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/bc060080h","article-title":"\u201cSMART\u201d drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers","volume":"17","author":"Sawant","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2022.114396_b0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/08982100701525035","article-title":"\u201cSmart\u201d drug carriers: PEGylated TATp-modified pH-sensitive liposomes","volume":"17","author":"Kale","year":"2007","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2022.114396_b0450","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2022.114396_b0455","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114396_b0460","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1600-065X.2000.00607.x","article-title":"B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganism","volume":"176","author":"Vos","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0465","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000233309","article-title":"Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins","volume":"70","author":"Richter","year":"1983","journal-title":"Int. Arch Allergy Appl. Immunol."},{"key":"10.1016\/j.addr.2022.114396_b0470","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acs.molpharmaceut.9b00770","article-title":"Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: the effect of PEG-lipid linkages and PEG molecular weights","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2022.114396_b0475","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0014-5793(02)03710-9","article-title":"PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance","volume":"532","author":"Gbadamosi","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114396_b0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.11.021","article-title":"An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil\u00ae, Caelyx\u00ae, DOXOrubicin, and SinaDoxosome","volume":"221","author":"Wibroe","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114396_b0485","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/nano10040787","article-title":"Stealth coating of nanoparticles in drug-delivery systems","author":"Fam","year":"2020","journal-title":"Nanomaterials10"},{"key":"10.1016\/j.addr.2022.114396_b0490","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1021\/acsnano.8b01806","article-title":"C1q-mediated complement activation and C3 opsonization trigger recognition of stealth poly(2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes","volume":"12","author":"Tavano","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2022.114396_b0495","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/acs.bioconjchem.5b00031","article-title":"Dendrimers in medicine: therapeutic concepts and pharmaceutical challenges","volume":"26","author":"Wu","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2022.114396_b0500","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/joim.12280","article-title":"Emerging concepts in dendrimer-based nanomedicines: from design principles to clinical applications","volume":"276","author":"Kannan","year":"2014","journal-title":"J. Int. Med."},{"key":"10.1016\/j.addr.2022.114396_b0505","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9343(70)80069-9","article-title":"The importance of erythrocyte deformability","volume":"49","author":"Weed","year":"1970","journal-title":"Am. J. Med."},{"key":"10.1016\/j.addr.2022.114396_b0510","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1073\/pnas.70.9.2663","article-title":"Enzyme loading of erythrocytes","volume":"70","author":"Ihler","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.addr.2022.114396_b0515","doi-asserted-by":"crossref","unstructured":"F.J. Alvarez, A. Herr\u00e1ez, J.C. Murciano, J.A. Jord\u00e1n, J.C. D\u00edez, M.C. TejedorIn vivo survival and organ uptake of loaded carrier rat erythrocytes, J. Biochem. 120 (1996) 286\u2013291.","DOI":"10.1093\/oxfordjournals.jbchem.a021411"},{"key":"10.1016\/j.addr.2022.114396_b0520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-4347(95)00433-5","article-title":"Heterogeneity of hypotonically loaded rat erythrocyte populations as detected by counter-current distribution in aqueous polymer two-phase systems","volume":"677","author":"P\u00e9rez","year":"1996","journal-title":"J. Chromatogr. B, Biomed. Appl."},{"key":"10.1016\/j.addr.2022.114396_b0525","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.162.1.75","article-title":"Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria","volume":"162","author":"Kinoshita","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2022.114396_b0530","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-1759(91)90291-M","article-title":"A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes","volume":"142","author":"Freysdottir","year":"1991","journal-title":"J. Immunol. Method."},{"key":"10.1016\/j.addr.2022.114396_b0535","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/jpet.109.159194","article-title":"Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis","volume":"332","author":"Zaitsev","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2022.114396_b0540","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/polym10090983","article-title":"Cell membrane-camouflaged nanoparticles: a promising biomimetic strategy for cancer theragnostics","volume":"10","author":"Vijayan","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2022.114396_b0545","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2022.114396_b0550","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.seminoncol.2020.05.009","article-title":"Just eat it: a review of CD47 and SIRP-\u03b1 antagonism","volume":"47","author":"Oronsky","year":"2020","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.addr.2022.114396_b0555","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1537-2995.2007.01348.x","article-title":"Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation","volume":"47","author":"Khandelwal","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.addr.2022.114396_b0560","article-title":"CD47\u2013SIRP\u03b1-targeted therapeutics: status and prospects","volume":"13","author":"Maute","year":"2022","journal-title":"Immuno-Oncol. Technol."},{"key":"10.1016\/j.addr.2022.114396_b0565","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1083\/jcb.200708043","article-title":"Inhibition of \u201cself\u201d engulfment through deactivation of myosin-II at the phagocytic synapse between human cells","volume":"180","author":"Tsai","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2022.114396_b0570","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcmd.2010.02.016","article-title":"Self inhibition of phagocytosis: the affinity of \u201cmarker of self\u201d CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels","volume":"45","author":"Tsai","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.addr.2022.114396_b0575","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/S0142-9612(03)00339-9","article-title":"Biomimetic materials for tissue engineering","volume":"24","author":"Shin","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2022.114396_b0580","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \u201cself\u201d peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.addr.2022.114396_b0585","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3389\/fphys.2019.00945","article-title":"Red blood cells: chasing interactions","volume":"10","author":"Pretini","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.addr.2022.114396_b0590","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1189\/jlb.71.4.652","article-title":"Erythrocytes deliver Tat to interferon-\u03b3-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro","volume":"71","author":"Corinti","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2022.114396_b0595","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/abio.1994.1559","article-title":"Attachment of biotinylated antibody to red blood cells: antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement","volume":"223","author":"Muzykantov","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.addr.2022.114396_b0600","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sinica B"},{"key":"10.1016\/j.addr.2022.114396_b0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.07.043","article-title":"Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: synergy between physical, chemical and biological approaches","volume":"68","author":"Anselmo","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2022.114396_b0610","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nnano.2017.47","article-title":"Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes","volume":"12","author":"Wibroe","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2022.114396_b0615","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1073\/pnas.94.14.7566","article-title":"Chemical camouflage of antigenic determinants: stealth erythrocytes","volume":"94","author":"Scott","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.addr.2022.114396_b0620","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0887-7963(00)80115-7","article-title":"Camouflaged blood cells: low-technology bioengineering for transfusion medicine?","volume":"14","author":"Scott","year":"2000","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.addr.2022.114396_b0625","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.addr.2022.114396_b0630","article-title":"Biomimetic carbon monoxide nanogenerator ameliorates streptozotocin induced type 1 diabetes in mice","volume":"245","author":"Zhang","year":"2020","journal-title":"Biomatertials"},{"key":"10.1016\/j.addr.2022.114396_b0635","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1039\/D1BM01664D","article-title":"Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery","volume":"10","author":"Khatoon","year":"2022","journal-title":"Biomat. Sci."},{"key":"10.1016\/j.addr.2022.114396_b0640","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nano.2015.09.005","article-title":"Platelet mimicry: the emperor\u2019s new clothes?","volume":"12","author":"Moghimi","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2022.114396_b0645","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2022.114396_b0650","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/annonc\/mdl477","article-title":"Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (\u2018hand-foot\u2019 syndrome)","volume":"18","author":"Lorusso","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2022.114396_b0655","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1021\/acsnano.2c00423","article-title":"PEGylated liposomes accumulate in the areas relevant to skin toxicities via passive extravasation across \u201cleaky\u201d endothelium","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2022.114396_b0660","first-page":"228","article-title":"Use of \u2018nano\u2019 prefix is no small matter","volume":"603","author":"Moghimi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.addr.2022.114396_b9000","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-4889(02)00204-5","article-title":"Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers","volume":"1590","author":"Moghimi","year":"2002","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22002861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22002861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:22:15Z","timestamp":1759209735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X22002861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":133,"alternative-id":["S0169409X22002861"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2022.114396","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief history of long circulating nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2022.114396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114396"}}